Jehoshaphat Research said in a research note to investors that it is short Dun & Bradstreet. The firm conducted a forensic investigation of the company and believes that its reported cash flows and earnings are “highly misleading.” It estimates 60%-80% downside to the share price, and anticipates the company will begin missing consensus expectations within the next 1-2 quarters. “This is a classic accounting short with very little upside and tremendous downside,” Jehoshaphat said.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DNB:
- Dun & Bradstreet Completes Eighth Amendment Transaction
- Dun & Bradstreet Holdings Refinances Loans, Amends Credit Agreement
- Dun & Bradstreet price target raised to $16 from $14 at Truist
- Dun & Bradstreet upgraded to Strong Buy from Outperform at Raymond James
- Dun & Bradstreet’s Bradstreet’s Data Cloud and IBM’s watsonx team on AI for biz
